INFUMORPH Drug Patent Profile
✉ Email this page to a colleague
When do Infumorph patents expire, and what generic alternatives are available?
Infumorph is a drug marketed by Hikma and is included in one NDA.
The generic ingredient in INFUMORPH is morphine sulfate. There are twenty-three drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the morphine sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Infumorph
A generic version of INFUMORPH was approved as morphine sulfate by HOSPIRA on September 30th, 1992.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for INFUMORPH?
- What are the global sales for INFUMORPH?
- What is Average Wholesale Price for INFUMORPH?
Summary for INFUMORPH
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 24 |
| Clinical Trials: | 5 |
| Patent Applications: | 4,623 |
| Drug Prices: | Drug price information for INFUMORPH |
| DailyMed Link: | INFUMORPH at DailyMed |
Recent Clinical Trials for INFUMORPH
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| M.D. Anderson Cancer Center | Early Phase 1 |
| National Cancer Institute (NCI) | Early Phase 1 |
| Abdelrady S Ibrahim, MD | Phase 2 |
Pharmacology for INFUMORPH
| Drug Class | Opioid Agonist |
| Mechanism of Action | Full Opioid Agonists |
US Patents and Regulatory Information for INFUMORPH
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hikma | INFUMORPH | morphine sulfate | INJECTABLE;INJECTION | 018565-003 | Jul 19, 1991 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma | INFUMORPH | morphine sulfate | INJECTABLE;INJECTION | 018565-004 | Jul 19, 1991 | AP | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
